Daniel Joseph Apel

ARWR

Daniel Joseph Apel serves as officer: Chief Financial Officer at Arrowhead Pharmaceuticals, Inc. (ARWR). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

1 trades

$934.3K

Net Position

Net Seller

$934.3K

Companies Traded

ARWR

Active Period

Apr 2026

1 total trades

Most Recent

Sell ARWR

Apr 24, 2026 · $934.3K

Daniel Joseph Apel's Insider Trading at Arrowhead Pharmaceuticals, Inc. (ARWR)

Buys

0 · $0.00

Sells

1 · $934.3K

Total Shares Bought

Total Shares Sold

13,095

ARWR Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Apr 24, 2026	Sell	13,095	$71.35	$934.3K	172,792

Related Insiders

James C Hamilton

officer: Chief Medical Officer

ARWRSell · Apr 24, 2026

Christopher Richard Anzalone

Chief Executive Officer

ARWRSell · Jan 2, 2026

Patrick O'Brien

COO

ARWRSell · Dec 31, 2025

Mauro Ferrari

Director

ARWRSell · Dec 26, 2025

William D. Waddill

Director

ARWRSell · Dec 19, 2025

OLUKOTUN ADEOYE Y

Director

ARWRSell · Dec 19, 2025

Victoria Vakiener

Director

ARWRSell · Dec 19, 2025

PERRY MICHAEL S

Director

ARWRSell · Dec 5, 2025

Explore More Insider Trading Data

ARWR Insider Trading Activity

View all insider trades at Arrowhead Pharmaceuticals, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity